热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 责任编辑：卢昱君 客户端 客户端 讯飞医疗科技（02506）早盘股价上涨6.04%，现报76.40港元，成交额1389.19万港元。 讯飞医疗科技公布，科大讯飞、科讯创投等共八名股东均承诺自原禁售期届满日期起至2026年12月29日 不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司5，575.84万股H股，占公司 H股总股本的68.25%；合计持有公司8，806.82万股股份，占公司总股本的72.86%。 公司认为，禁售期延长表明前述股东对公司的未来前景充满信心。前述股东亦将持续审阅公司业绩，且 或将基于公司的业务发展情况考虑进一步延长禁售期。 讯飞医疗科技（02506）早盘股价上涨6.04%，现报76.40港元，成交额1389.19万港元。 讯飞医疗科技公布，科大讯飞、科讯创投等共八名股东均承诺自原禁售期届满日期起至2026年12月29日 不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司5，575.84万股H股，占公司 H股总股本的68.25%；合计持有公司8，806.82万股股份，占公司总股本的72.86%。 公 ...

消息面上，讯飞医疗科技公布，科大讯飞、科讯创投等共八名股东均承诺自原禁售期届满日期起至2026 年12月29日不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司5,575.84万股H 股，占公司H股总股本的68.25%；合计持有公司8,806.82万股股份，占公司总股本的72.86%。 智通财经APP获悉，讯飞医疗科技(02506)早盘涨超4%，截至发稿，涨4.09%，报75港元，成交额 1052.06万港元。 公司认为，禁售期延长表明前述股东对公司的未来前景充满信心。前述股东亦将持续审阅公司业绩，且 或将基于公司的业务发展情况考虑进一步延长禁售期。 ...

公司认为，禁售期延长表明前述股东对公司的未来前景充满信心。前述股东亦将持续审阅公司业绩，且 或将基于公司的业务发展情况考虑进一步延长禁售期。 消息面上，讯飞医疗科技公布，科大讯飞（002230）、科讯创投等共八名股东均承诺自原禁售期届满日 期起至2026年12月29日不会以任何方式减持公司H股或非上市股份。目前该八名股东合计持有公司 5,575.84万股H股，占公司H股总股本的68.25%；合计持有公司8,806.82万股股份，占公司总股本的 72.86%。 讯飞医疗科技(02506)早盘涨超4%，截至发稿，涨4.09%，报75港元，成交额1052.06万港元。 ...

Group 1 - In 2025, Xi Jinping emphasized the importance of grassroots efforts and practical actions for economic and social development during his inspections in various regions [1][3] - Shanghai's Xu Hui District has gathered over 1,500 AI companies and established a 2 billion yuan "Shanghai Xu Hui AI Youth Entrepreneurship Fund" to support innovation and entrepreneurship [3][4] - The Qingpu District has implemented "industrial upgrading" strategies to maximize production space for innovative companies, facilitating their growth [4][5] Group 2 - Liaoning Province has prioritized optimizing the business environment, resulting in 480 companies securing financing agreements totaling 1.74 billion yuan [7][8] - The Taian County has introduced 55 innovative measures to enhance the business environment, including establishing a "no proof city" initiative and facilitating financing for local enterprises [7][8] - The county has organized quarterly "government-bank-enterprise" financing demand meetings to promote financial products tailored for small and medium-sized enterprises [8] Group 3 - In Shanxi, the Jin Cheng Economic and Technological Development Zone has introduced a "white list + risk compensation fund" mechanism to facilitate financing for innovative enterprises [9][10] - The local government is actively supporting the transformation of traditional industries while fostering new strategic industries, contributing to a significant increase in the output value of the optical and mechanical industry [10][11] - The government has established a mechanism for rapid response to enterprise needs, ensuring smooth project advancement and addressing financing challenges [11] Group 4 - In Henan, the Zhengzhou government has implemented measures to reduce bureaucratic burdens on grassroots officials, allowing them to focus more on community needs [12][13] - The local government has streamlined assessment processes, achieving a 73.89% reduction in evaluation indicators, enabling officials to engage more with the community [12][13] - Community initiatives have been launched to improve local infrastructure and services, fostering greater collaboration between officials and residents [13] Group 5 - In Yunnan, the local government is promoting ecological development while ensuring community livelihoods through sustainable practices [15][16] - The region has implemented a model of "using fish to nourish water" for ecological aquaculture, enhancing both environmental quality and local income [16] - The local government has conducted extensive vocational training and created public service jobs to support the community's transition to sustainable livelihoods [16]

Group 1 - In 2025, Xi Jinping emphasized the importance of local economic and social development during his inspections, guiding various regions towards progress [1] - Shanghai is focusing on becoming a leader in artificial intelligence development, with over 1,500 AI companies currently in the Xuhui District [3] - The Xuhui District has established a 2 billion yuan "Shanghai Xuhui AI Youth Entrepreneurship Fund" to support early-stage entrepreneurs [3] Group 2 - Liaoning Province has implemented 55 innovative measures to optimize the business environment, facilitating financing agreements for over 480 companies, totaling 1.74 billion yuan [6][7] - The establishment of a "政银企" financing demand meeting in Tai'an County has helped local enterprises secure loans and improve their operational capabilities [7] - The Tai'an County government has actively supported companies like Jinhe Recycling Resources Co., helping them secure 190 million yuan in supply chain loans [7] Group 3 - In Shanxi, the Jincheng Economic and Technological Development Zone is promoting the optical and mechanical industry as a strategic focus for economic transformation [8][9] - The local government has introduced a "white list + risk compensation fund" mechanism to facilitate financing for innovative companies lacking collateral [8] Group 4 - In Henan, the Zhengzhou government has implemented measures to reduce bureaucratic burdens on grassroots officials, allowing them to focus more on community needs [11][12] - The local government has streamlined 86 items from its administrative checklist, enabling officials to engage more directly with residents [12] Group 5 - In Yunnan, the local government is promoting ecological development while ensuring community livelihoods, with initiatives like repairing roads to support oil tea production [14][15] - The region has successfully integrated ecological protection with economic development, attracting nearly 6 million tourists by promoting sustainable tourism [15]

截至本公告日期，前述股东合计持有公司5275.84万股H股，占公司H股总股本的68.25%;合计持有公司 8806.82万股股份，占公司总股本的72.86%。 公司认为，禁售期延长表明前述股东对公司的未来前景充满信心。前述股东亦将持续审阅公司业绩，且 或将基于公司的业务发展情况考虑进一步延长禁售期。 讯飞医疗科技(02506)发布公告，近日，公司接获以下股东的通知： (1)科大讯飞（002230）股份有限公司("科大讯飞"，截至本公告日期持有公司29,869,072股非上市股份及 29,869,073股H股);(2)安徽科讯创业投资基金合伙企业(有限合伙)("科讯创投"，截至本公告日期持有公司 17,448,567股H股);(3)赵志伟先生(于公司员工持股平台合肥正昇信息科技合伙企业(有限合伙)("合肥正 昇")及南京正旸信息科技合伙企业(有限合伙)("南京正旸")中持有合伙权益，截至本公告日期，其所持有 的合伙权益对应公司1,577,313股非上市股份及1,577,313股H股);(4)陶晓东博士(于合肥正昇及南京正旸中 持有合伙权益，截至本公告日期，其所持有的合伙权益对应公司1,542,261股非上市股份 ...

Core Insights - The article discusses a unique examination conducted at Peking University, where advanced AI models such as GPT, Gemini, and DeepSeek competed against 174 undergraduate students in the College of Chemistry and Molecular Engineering [1][2] - The examination aimed to assess whether AI truly understands chemistry, utilizing a specially designed test that emphasizes reasoning over rote memorization [3][6] Group 1: Examination Design - The test comprised 500 challenging questions derived from high-level academic literature, specifically tailored to prevent AI from relying on memorized content [2][4] - A collaborative platform was created for the team of nearly 100 students and faculty to design, review, and refine the questions, incorporating a gamified points system to enhance engagement [4] Group 2: Results and Performance - The average accuracy of the participating students was 40.3%, indicating the high difficulty level of the exam [6] - AI models performed at a level comparable to that of first-year undergraduate students, revealing limitations in their ability to process visual information and complex reasoning tasks [7] Group 3: SUPERChem Project - The SUPERChem project fills a gap in multi-modal deep reasoning assessments in the field of chemistry, serving as a benchmark for future AI development [8] - The project has been fully open-sourced, with the intention of contributing to the global scientific and AI community, highlighting the journey from knowledge retention to understanding the physical world [8]

Core Insights - The AI medical application "Ant Financial Afo" has rapidly gained popularity, reaching the third position in Apple's free app rankings shortly after its launch on December 15, indicating a strong market demand for AI medical applications [1] - The AI medical sector is entering a critical phase of commercialization, driven by national strategies and market needs, with significant participation from medical institutions and the deployment of large models across various departments [1] Policy and Infrastructure - National policies are continuously improving to support AI in healthcare, with specific guidelines outlining 24 key applications across eight areas, including clinical diagnosis and patient services [2] - The National Medical Insurance Administration has included "AI-assisted diagnosis" in the pathology diagnosis expansion items, paving the way for its inclusion in the medical insurance reimbursement system [2] - Local governments are also implementing supportive measures, such as Zhejiang's action plan to establish a national AI medical application base by 2027, focusing on the "Anzhener" medical model [2] Industry Development - The establishment of the Zhejiang AI Medical Application Pilot Base is accelerating infrastructure development, providing a comprehensive platform for model research, validation, and application promotion [3] - This base aims to lower innovation barriers and technical validation costs, fostering a cluster effect in the industry and enhancing the standardization and intelligence of the healthcare sector [3] Corporate Strategies - Various companies are actively entering the AI medical field, leveraging favorable policies and a mature market environment [4] - Zhejiang Heren Technology has developed a product matrix centered around its AI application development platform, including AI clinical workstations and mobile diagnostic assistants to improve efficiency [4] - Shanghai RunDa Medical Technology is focusing on digital transformation in healthcare, developing over 20 AI products across clinical assistance, patient management, and research innovation [4] - Companies are also targeting high-barrier niche markets, such as Jiangsu Kangzhong Digital Medical Technology, which showcased its low-dose imaging solution at a major radiology conference [4] Future Outlook - The AI medical sector has significant growth potential, with AI technologies providing scientific support across various healthcare processes, including disease prevention and personalized treatment [5] - Companies are advised to focus on high-barrier segments requiring certification and develop low-code AI tools for grassroots medical institutions to capture long-tail markets [5] - Emphasizing algorithm transparency and compliance with medical regulations while integrating with regional healthcare data platforms is crucial for innovation [5]

Core Insights - Wuhan is emerging as a significant global innovation hub, with a rapid increase in high-tech enterprises and innovative achievements driven by application demand [1][2] - The city has seen a substantial rise in the number of academicians and high-tech enterprises, indicating a strong foundation for innovation [2][6] - A comprehensive innovation ecosystem is being established in Wuhan, integrating various resources and breaking traditional research barriers [3][4] Group 1: Innovation and Research Growth - The number of high-tech enterprises in Wuhan has surpassed 17,000, which is 2.72 times that of 2020, showcasing a robust growth trajectory [1] - Wuhan ranks fourth nationally in the number of academicians, with 91 academicians contributing to its talent pool, which is crucial for fostering innovation [2] - The city has been recognized as the 8th in the global "Nature Index - Research Cities" ranking, reflecting its status as a key innovation growth pole [2] Group 2: Infrastructure and Facilities - Wuhan has established 41 national key laboratories, leading the nation in terms of quantity, which serve as foundational engines for basic research [4] - The city is developing 10 large scientific facilities that will enable original innovations, including a pulsed strong magnetic field facility that can generate a magnetic field 2 million times stronger than Earth's [4][5] - The construction of the Han River National Laboratory is expected to attract over 2,000 high-end research talents and drive related industry investments exceeding 10 billion [5] Group 3: Commercialization and Application - The "Han Yuan 1" quantum computer, developed in Wuhan, has entered commercial application, securing over 40 million in orders, marking a significant step in the commercialization of quantum computing [7] - Collaborative efforts among hospitals, universities, and enterprises have led to the successful development of a multimodal imaging surgical robot, achieving a 100% success rate in surgeries [7] - Wuhan has established a nurturing ecosystem for over 500 enterprises across seven new sectors, supported by 210 municipal pilot platforms and 32 concept validation centers [8]

12月26日，天眼查融资历程显示，杭州印生医疗科技有限公司近日获得"Pre-A轮"融资，涉及融资金额 数千万人民币，投资机构为熔拓资本，临平国投，东方国资，华禹创投。 天眼查信息显示，杭州印生医疗科技有限公司的股东为：贺永、杭州普诺威企业管理合伙企业（有限合 伙）、杨华勇、张景波、杭州璿石投资合伙企业（有限合伙）。 资料显示，杭州印生医疗科技有限公司法定代表人为张景波，成立于2022年，位于杭州市，是一家以从 事研究和试验发展为主的企业。企业注册资本110万人民币，并已于2025年完成了Pre-A轮，交易金额数 千万人民币。 来源：市场资讯 通过天眼查大数据分析，杭州印生医疗科技有限公司共对外投资了1家企业，知识产权方面有商标信息 14条，专利信息9条，此外企业还拥有行政许可4个。 ...